Yan Hu

ORCID: 0000-0002-7159-9095
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Surface and Contact Lens
  • RNA Research and Splicing
  • Optical Systems and Laser Technology
  • Ovarian cancer diagnosis and treatment
  • Breast Lesions and Carcinomas
  • Infrared Target Detection Methodologies
  • Cancer Genomics and Diagnostics
  • Medical Imaging and Analysis
  • RNA and protein synthesis mechanisms
  • CCD and CMOS Imaging Sensors
  • Lung Cancer Diagnosis and Treatment
  • HER2/EGFR in Cancer Research
  • Geological Modeling and Analysis
  • Lung Cancer Treatments and Mutations
  • Food Allergy and Anaphylaxis Research
  • Medical Imaging Techniques and Applications
  • RNA regulation and disease
  • Cancer Immunotherapy and Biomarkers
  • Lymphoma Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Eosinophilic Esophagitis
  • Bee Products Chemical Analysis
  • Pediatric health and respiratory diseases
  • Corneal surgery and disorders
  • Tuberous Sclerosis Complex Research

Nanjing Medical University
2010-2025

Wenzhou Medical University
2024

First Affiliated Hospital of Wenzhou Medical University
2024

Jiangsu Province Hospital
2024

The Ohio State University
2022

The University of Texas MD Anderson Cancer Center
2022

Children's Hospital of Chongqing Medical University
2020

Chongqing Medical University
2020

The First Affiliated Hospital, Sun Yat-sen University
2019

Zhongshan Hospital
2019

This study compares the corneal temperature in dry eyes with normal via high-resolution infrared thermography. A total of 86 participants were enrolled, 40 and 46 eye disease (DED) control groups, respectively. All underwent non-invasive breakup time (NIBUT) measurement, an Ocular Surface Disease Index (OSDI) questionnaire ocular In DED group, mean initial central (initial CCT) is 33.25 ± 0.66°C, tenth-second (10s-CCT) 32.47 0.84°C, change measured within 10 s (change CCT s) 0.78 0.30°C. For...

10.3389/fmed.2024.1526165 article EN cc-by Frontiers in Medicine 2025-01-07

This study aimed to analyze the safety and applicability of a 90-min duration infusion (SDI) obinutuzumab in patients with B-cell non-Hodgkin's lymphoma (NHL) tertiary hospital China. exploratory clinical trial was performed at Jiangsu Province Hospital. All were treated standard regimen for first infusion. If no grade ≥3 infusion-related reactions (IRRs) occurred, subsequent infusions given as SDI. The primary endpoint incidence IRR during (3-4 h) SDI regimens. enrolled 208 all completed...

10.1590/1414-431x2023e13284 article EN cc-by Brazilian Journal of Medical and Biological Research 2024-01-01

This study conducts a bibliometric literature analysis to explore trends in immunotherapy for ovarian cancer from 2019 2023.

10.3389/fimmu.2024.1465917 article EN cc-by Frontiers in Immunology 2024-10-03

Background: Some studies have found a slowly increasing or decreasing trend of FA. However, the trends FA in China are unknown. To investigate prevalence and characteristic changes children aged <2 years across 20 years. Methods: Data from three cross-sectional surveys on epidemiology conducted 1999, 2009, 2019 were assessed, outcomes compared. The skin prick test was performed all participants; open food challenge tests used for diagnosis confirmation. Results: prevalences 2009...

10.22541/au.159549302.22473472 preprint EN Authorea (Authorea) 2020-07-23

Abstract Purpose The recent WHO classification of breast cancer (2019) categorizes carcinoma with neuroendocrine (NE) differentiation into three morphologically distinct subtypes: well-differentiated tumor (NET), poorly differentiated (NEC), and invasive carcinoma, no special type (IBC-NST-NE). Data regarding the prognostic significance are conflicting an association, if any, between p53 mutation is largely unknown. Methods We examined expression other clinicopathologic characteristics in...

10.21203/rs.3.rs-1841981/v1 preprint EN cc-by Research Square (Research Square) 2022-08-01

10.3980/j.issn.1672-5123.2021.12.17 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2021-12-01
Coming Soon ...